FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
基本信息
- 批准号:2442700
- 负责人:
- 金额:$ 23.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-07-15 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) Large amounts of HIV
are trapped on follicular dendritic cells (FDC) in the germinal centers of
secondary lymphoid tissues. throughout clinical latency when CD+4 T cells
continually decline, these germinal centers with virus-laden FDC, highly
activated, CD+4 T cells and a state of high cellular activation are the
primary sites of active HIV replication. The investigators hypothesize that
FDC play a major role in HIv pathogenesis by: (1) serving as a reservoir of
infectious HIV; (2) potentiating both de novo infection of newly entering
cells and of latently infected cells coming into the germinal center; and
(3) by permitting infection in the presence of high levels of neutralizing
antibody. They also hypothesize that FDC features that promote infection
may be able to be inhibited. In support of the hypothesis, they have
recently shown that FDC trapped HIV immune complexes are highly infectious
and they have data suggesting that FDC maintain HIV infectivity even in the
absence of viral replication. They also have evidence that FDC promote a
significant increase in the amount of HIV infection in both newly and
latently infected T cells. Lastly they have found that FDC permit infection
even in the presence of a vast excess of neutralizing antibody.
The investigators believe that their hypothesis is exciting and that an
understanding of FDC contributions to HIV pathogenesis will be critical in
designing intervention strategies that can attack this reservoir of
infectious virus. Current strategies to stop viral replication do not
target the FDC reservoir which remains until the cells are destroyed and the
lymph node involutes prior to the onset of AIDS. thus an understanding of
FDC contributions may allow them to successfully target this important cell
and its viral reservoir.
描述:(改编自研究者摘要)大量HIV
被困在滤泡树突状细胞(FDC)的生发中心,
次级淋巴组织 当CD+4 T细胞
持续下降,这些带有病毒负载FDC的生殖中心,
活化的CD+4 T细胞和高细胞活化状态是
艾滋病毒活跃复制的主要场所。 研究人员假设,
FDC通过以下方式在HIV发病机制中发挥主要作用:(1)作为HIV的储存库,
感染性HIV;(2)加强新进入的新生感染和
细胞和潜伏感染的细胞进入生殖中心;和
(3)通过在存在高水平的中和抗体的情况下允许感染,
抗体的 他们还假设FDC促进感染的特征
可能会被抑制。 为了支持这一假设,他们
最近表明,FDC捕获的HIV免疫复合物具有高度传染性,
他们有数据表明,FDC即使在
没有病毒复制。 他们也有证据表明,FDC促进了
新感染和感染艾滋病毒的人数均显着增加
潜伏感染的T细胞 最后,他们发现FDC允许感染
即使在中和抗体大量过量的情况下。
研究人员认为,他们的假设令人兴奋,
了解FDC对HIV发病机制的贡献将是至关重要的,
设计干预策略,
传染性病毒 目前阻止病毒复制的策略
靶向FDC储库,其保留直到细胞被破坏,
淋巴结在艾滋病发病前就已退化。 因此,
FDC的贡献可能使他们能够成功地瞄准这一重要细胞
和它的病毒库
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory F. Burton其他文献
Gregory F. Burton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory F. Burton', 18)}}的其他基金
Follicular dendritic cell activation and HIV pathogenesis
滤泡树突状细胞激活和 HIV 发病机制
- 批准号:
8012521 - 财政年份:2010
- 资助金额:
$ 23.86万 - 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
- 批准号:
2076912 - 财政年份:1996
- 资助金额:
$ 23.86万 - 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
- 批准号:
2887219 - 财政年份:1996
- 资助金额:
$ 23.86万 - 项目类别:
Follicular Dendritic Cells and HIV Pathogenesis
滤泡树突状细胞和 HIV 发病机制
- 批准号:
7073866 - 财政年份:1996
- 资助金额:
$ 23.86万 - 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
- 批准号:
2672780 - 财政年份:1996
- 资助金额:
$ 23.86万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 23.86万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 23.86万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 23.86万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 23.86万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 23.86万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 23.86万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 23.86万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 23.86万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 23.86万 - 项目类别:
Standard Grant